The discussion offers no high-conviction stock trade: Peloton (PTON) is mentioned only as a possible HSA/FSA-eligible purchase, with no evidence on sales or outlook. Treat preventive-health financing, consumer diagnostics, and wellness products as themes to research—not investment recommendations—since no company financials, valuations, or price targets are provided.

TrueMed (private company; no ticker mentioned)

• Co-founder and CEO Justin Mares described TrueMed as a platform that helps eligible customers use HSA/FSA funds for certain lifestyle-oriented interventions, such as exercise, supplements, healthy food, and sleep aids, when supported by a doctor’s note.
• Mares framed the business around a perceived gap between spending on chronic-disease treatment and spending on prevention. He said less than 3% of healthcare spending goes toward prevention or lifestyle interventions, while much more goes toward managing chronic conditions.

Takeaways

• The discussion points to a potential investment theme in preventive-health financing and consumer health platforms.
• The transcript provides no information on TrueMed’s revenue, growth, valuation, or customer adoption, so it does not establish an investment case. The eligibility process described also depends on qualifying circumstances and a doctor’s note.

Peloton (PTON)

• Peloton was named as an example of exercise equipment that a qualified customer might be able to purchase using HSA/FSA funds through TrueMed.

Takeaways

• This mention suggests a possible connection between tax-advantaged health spending and demand for fitness products, but the podcast gives no sales, financial, or outlook information about Peloton.
• Treat the reference as an example of a potentially eligible purchase—not as a bullish stock recommendation.

Eight Sleep (private company; no ticker mentioned)

• Eight Sleep was also cited as an example of a sleep-related product that a qualified customer might be able to purchase through TrueMed using HSA/FSA funds.

Takeaways

• The discussion highlights sleep technology as part of the broader consumer wellness market.
• No company performance, market-size, or valuation information was provided, so the mention alone does not support an investment conclusion.

Preventive-health diagnostics and testing

• Mares said he gets blood work about every six months and described periodic scans, including an artery calcium test and an Ezra scan. He characterized Ezra as a way to look for precancerous growths.
• The discussion reflects interest in consumers monitoring health data and using testing to guide personal health decisions.

Takeaways

• Consumer diagnostics and preventive testing are themes to monitor, but the transcript offers no investment details about Ezra or diagnostic companies generally.
• Mares’s testing routine is personal experience, not evidence that a particular testing approach or company will produce better outcomes or investment returns.

Health and wellness product brands

• Maui Nui was mentioned for an organ-based supplement.
• Thorne was mentioned as the maker of a supplement Mares takes for eye health.
• Toku was named as the brand of a nattokinase supplement Mares takes for heart-health concerns; he described it as having a dose he believes is supported by research.
• ALECS was mentioned for regenerative ice cream, which Mares described as an occasional indulgence.
• Branch Basics was mentioned as a source of cleaning products.

Takeaways

• These examples point to consumer interest in supplements, functional foods, and household wellness products.
• The transcript does not provide financial information or independent evidence for the health claims discussed. None of these product mentions, by themselves, amount to an investment recommendation.

Broader investment themes

• Mares emphasized preventive care, lifestyle interventions, consumer access to health data, and using HSA/FSA funds for eligible health-related purchases.
• He also discussed consumer spending on higher-quality foods, water and air filtration, and other home-environment products.

Takeaways

• These topics may be useful areas for investors to research, but the episode does not identify specific public-market opportunities beyond Peloton (PTON) or provide price targets, forecasts, or recommendations.
• The transcript mentions no cryptocurrencies. It also includes a general disclosure that a16z and its affiliates may invest in companies discussed, without specifying which companies.